Grand River Aseptic Manufacturing, a Michigan-based fill-finish CMO, says it has acquired a 1.5-acre plot of land near its current manufacturing facility as part of a planned expansion of its production capacity. More: Grand River buys more land to expand
read moreReckitt Benckiser is officially bowing out of the race for Pfizer’s consumer health unit, paving the way for GlaxoSmithKline to make a move. But at least one analyst thinks Pfizer shouldn’t go through with a sale. More: Reckitt's the latest
read moreAs Sanofi presses ahead with the sale of its European generics unit, a private equity firm has reportedly bowed out over price. Analysts have said the business could fetch €2 billion for the French drugmaker, which is streamlining to focus on
read moreA combination of venetoclax and rituximab being developed by AbbVie and Roche/Genentech significantly improved progression-free survival (PFS) in patients with chronic lymphocytic leukaemia (CLL), shows data published by the New England Journal of Medicine. More: NEJM publishes venetoclax/rituximab data Source:
read moreCost regulators for NHS therapies in England and Wales have now published final guidelines backing the use of LEO Pharma’s Kyntheum as an option for treating severe plaque psoriasis. More: Psoriasis patients get NHS access to LEO Pharma’s Kyntheum Source:
read moreAkcea Therapeutics’ volanesorsen will be available to eligible patients in the UK before it is officially licensed in the EU, having been granted entry to the country’s Early Access to Medicines Scheme. More: UK patients get early access to Akcea’s
read more© 1994 - 2026 B.M. Pharmaceuticals